Eledon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $384 |
Gross Profit | -88 | |||
EBITDA | -17,459 | -24,733 | -6,494 | -44,098 |
EBIT | -24,458 | -44,186 | ||
Net Income | -17,459 | -11,216 | -6,495 | -44,617 |
Net Change In Cash | 0 | 0 | 0 | 384 |
Free Cash Flow | -14,477 | -17,713 | -16,060 | -18,987 |
Cash | 3,669 | 5,741 | 8,496 | 20,549 |
Basic Shares | 77,156 | 77,156 | 77,126 | 59,789 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $120 |
Gross Profit | -359 | -374 | -373 | 120 |
EBITDA | -35,394 | -42,626 | -87,593 | -36,672 |
EBIT | -35,753 | -43,000 | -87,966 | -36,867 |
Net Income | -36,184 | -40,326 | -87,966 | -34,506 |
Net Change In Cash | 0 | 0 | 0 | 120 |
Free Cash Flow | -47,271 | -39,527 | -28,424 | -28,913 |
Cash | 20,549 | 4,612 | 56,409 | 84,833 |
Basic Shares | 48,543 | 24,619 | 14,285 | 14,819 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.21 |
2025-06-30 | -$0.13 |
2025-03-31 | -$0.08 |
